Antisynthetase Syndrome (ASS) Not Yet Recruiting Phase 3 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0115994 (Antisynthetase Syndrome (ASS))Not Yet Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03770663Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung DiseaseTreatment